Why Is Carbocaine with Neo-Cobefrin So Hard to Find? [Explained for 2026]

If your dentist has ever had to switch anesthetics mid-appointment, or if you've been told your procedure needs to be rescheduled because the usual numbing medication isn't available, you're not alone. Carbocaine 2% with Neo-Cobefrin — the brand name for mepivacaine hydrochloride with levonordefrin — has long been a staple of dental practices. But sourcing it isn't always straightforward.

In this article, we break down why this particular dental anesthetic can be hard to find, what that means for patients and dental teams, and what you can do if your dentist or oral surgeon is struggling to get it in stock.

What Is Carbocaine with Neo-Cobefrin?

Carbocaine 2% with Neo-Cobefrin is a sterile injectable dental anesthetic combining two active ingredients: mepivacaine hydrochloride (the anesthetic) and levonordefrin (the vasoconstrictor). Sold in 1.7 mL single-dose dental cartridges and packaged 50 per box, it's used by dentists to numb specific areas of the mouth before procedures such as fillings, root canals, extractions, and periodontal surgery.

What makes this formulation unique is the vasoconstrictor. Levonordefrin (also called Neo-Cobefrin) is less potent than epinephrine in raising blood pressure, making Carbocaine with Neo-Cobefrin a preferred choice for patients with certain cardiovascular conditions. It provides a longer duration of anesthesia — up to 2.5 hours in the upper jaw and 5.5 hours in the lower jaw — compared to plain (no vasoconstrictor) formulations.

Why Does Carbocaine with Neo-Cobefrin Become Unavailable?

There are several factors that can make this drug hard to source at any given time:

1. Levonordefrin Is a Niche Vasoconstrictor

In North America, levonordefrin is the only vasoconstrictor used in dental cartridges besides epinephrine. Because it's used almost exclusively with mepivacaine 2%, its manufacturing volume is much lower than epinephrine-based formulations. Any disruption in the supply chain for levonordefrin can directly impact availability of Carbocaine with Neo-Cobefrin.

2. A History of Manufacturing Disruptions

Carbocaine with Neo-Cobefrin has a documented history of supply interruptions. At one point, Eastman Kodak Company — which owned the Cook-Waite brand at the time — discontinued production entirely because a key ingredient was no longer available from its supplier. The product was later reintroduced after manufacturing was restructured. Today, it is produced by Septodont, Inc. (formerly Novocol Pharmaceutical of Canada), but the product's complex formulation means it remains more susceptible to supply chain disruptions than simpler anesthetic formulations.

3. Limited Number of Manufacturers

Unlike drugs with dozens of generic manufacturers, Carbocaine with Neo-Cobefrin is produced by a small number of companies. When one supplier has a production slowdown, regulatory hold, or raw material shortage, there are few backup sources to fill the gap. The dental supply chain is already lean — dental offices typically order from distributors who then order from a handful of manufacturers.

4. Demand Spikes After Shortages

When Carbocaine with Neo-Cobefrin returns to market after a shortage, dental offices tend to stockpile to avoid future gaps. This panic buying can create secondary shortages at the distributor level, even when manufacturing has returned to normal capacity. If your dental office is currently having trouble getting it, they may be competing with dozens of other practices trying to do the same thing.

Who Is Most Affected by Carbocaine with Neo-Cobefrin Shortages?

Most patients won't notice a shortage directly — their dentist will simply switch to a different local anesthetic for their appointment. But some patient populations are more significantly affected:

Patients with cardiovascular disease who need an anesthetic with a milder vasoconstrictor than epinephrine

Patients who have had adverse reactions to epinephrine-containing anesthetics

Patients undergoing long procedures that require extended anesthesia duration (2.5–5.5 hours)

Dental practices that have standardized on mepivacaine with levonordefrin for specific clinical protocols

What Can Patients Do?

If you have a dental appointment and your dentist typically uses Carbocaine with Neo-Cobefrin due to a medical condition, here's what you can do:

Call your dentist's office ahead of your appointment to confirm the specific anesthetic they plan to use

Ask your dentist whether an alternative anesthetic (such as plain mepivacaine 3% or prilocaine 4%) would be medically appropriate for you

If you need a procedure urgently and your dentist cannot source Carbocaine with Neo-Cobefrin, ask for a referral to another provider who has it in stock

Need help finding a dental or medical provider that has this medication in stock? medfinder contacts providers near you to check medication availability — so you don't have to spend hours calling around yourself.

The Bottom Line

Carbocaine with Neo-Cobefrin's availability challenges come down to a perfect storm: a niche vasoconstrictor, a small manufacturing base, and a history of supply disruptions. For most patients, your dentist can work around a temporary shortage. But if your medical history requires this specific formulation, it's worth staying proactive. Read our 2026 shortage update for the latest information on current supply status.